The World Health Organ­isation (WHO) has opened the door to routine immunization of infants in sub-Saharan Afri­ca by approving for use an inno­vative and affordable vaccine that has all but rid the meningi­tis belt of a major cause of dead­ly epidemics.

In the four years since its in­troduction in Africa, MenAfri­Vac® has had an immediate and dramatic impact in breaking the cycle of meningitis A epidem­ics, leading the safe, effective technology to be approved by WHO through its pre-qualifica­tion process for use in infants, and paving the way for protect­ing millions more children at risk of the deadly disease.

No Comments

Leave a Comment